Study Objective: To study the dynamics of lung compartments by dynamic CT (dCT) imaging during uninterrupted pressure-controlled ventilation (PCV) and different positive end-expiratory pressure (PEEP) settings in healthy and damaged lungs.
Design: Experimental animal investigation.
Setting: Experimental animal facility of a university department.
Interventions: In seven anesthetized pigs, static inspiratory pressure volume curves were obtained to identify the individual lower inflection point (LIP) before and after saline solution lung lavage. During PCV, PEEP was adjusted 5 millibars (mbar) below the individually determined LIP (LIP - 5), at the LIP, and 5 mbar above the LIP (LIP + 5).
Measurements And Results: Measurements were repeated before and after induction of lung damage. Hemodynamics, arterial and mixed venous blood gases, and dCT imaging in one juxtadiaphragmatic slice (effective temporal resolution of 100 ms) were assessed during uninterrupted PCV in series of three successive respiratory cycles. The mean fractional area (FA) of the hyperinflated lung (FA-H), mean FA of ventilated lung, mean FA of poorly ventilated lung, and mean FA of nonventilated lung (FA-NV), and the change in FA of the whole lung area (DeltaFA) were compared at different PEEP settings. Calculated pulmonary shunt (Qs/Qt) was compared to FA-NV. LIP + 5 decreased the amount of atelectasis (FA-NV) and increased hyperinflation (FA-H) in healthy and injured lungs. Cyclic changes of atelectasis (DeltaFA-NV) and hyperinflation (DeltaFA-H) were observed in both healthy and injured lungs. In the injured but not in the healthy lungs, the amount of cyclic changes of atelectasis and hyperinflation were independent from the adjusted PEEP level. FA-NV correlated with the calculated Qs/Qt, with a slight overestimation (mean +/- SEM, 2.1 +/- 4.1%).
Conclusions: dCT imaging allows the following: (1) the quantification of the extent of atelectasis, ventilated, poorly ventilated, and hyperinflated lung parenchyma during ongoing mechanical ventilation; (2) the detection and quantification of repeated recruitment and derecruitment, as well as hyperinflation; and (3) an estimation of Qs/Qt. dCT adds promising functional information for the respiratory treatment of early ARDS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1378/chest.128.5.3757 | DOI Listing |
ERJ Open Res
January 2025
Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Background: Data regarding the effectiveness and safety of endoscopic lung volume reduction with valves (ELVR) in emphysema patients with a very low 6-min walk test (6MWT) are limited. Patients with severe emphysema and very low exercise capacity, as indicated by a 6MWT ≤140 m, are often excluded from clinical studies on ELVR, assuming limited therapeutic benefits and increased complication risk.
Study Designs And Methods: This study utilised data from the Lungenemphysemregister e.
Respir Med Case Rep
December 2024
Section of Pulmonary, Critical Care and Sleep Medicine Carilion Clinic, Virginia Tech School of Medicine, USA.
Chronic obstructive lung disease is the third leading cause of death worldwide. It affects the airways and lung parenchyma leading to emphysema. Bronchoscopic lung volume reduction is another strategy that aims to reduce air trapping and hyperinflation, leading to improvement in symptoms and pulmonary function.
View Article and Find Full Text PDFRespir Med Res
December 2024
Département de Pneumologie, CHRU Nancy, Vandoeuvre-Lès Nancy, France; INSERM U1254 IADI, Université de Lorraine, Nancy, France. Electronic address:
Background: Pulmonary hypertension (PH) is common during chronic obstructive pulmonary disease (COPD), particularly in patients with severe COPD. These patients can be classified into different PH groups due to frequent comorbidities. Emphysema is often associated with COPD and is responsible for lung hyperinflation, which may contribute to the development of PH.
View Article and Find Full Text PDFEur Respir J
January 2025
Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium
https://bit.ly/4eWTNy8
View Article and Find Full Text PDFIntroduction: Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death globally, characterized by airflow limitation and lung hyperinflation due to emphysema. Bronchoscopic lung volume reduction (BLVR) with endobronchial valves offers a minimally invasive treatment option for emphysema, aiming to reduce lung hyperinflation, thereby improving lung function and exercise tolerance.
Methods: This study evaluated the efficacy of BLVR in a real-life nationwide setting using comprehensive Danish registries.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!